Singapore markets close in 5 hours 13 minutes
Straits Times Index
3,434.34 +18.83 (+0.55%) Nikkei
40,666.78 +86.02 (+0.21%) Hang Seng
18,017.90 +39.33 (+0.22%) FTSE 100
8,171.12 +49.92 (+0.61%) Bitcoin USD
58,981.60 -1,969.27 (-3.23%) CMC Crypto 200
1,234.36 -100.55 (-7.53%)
Rohto Pharmaceutical Co.,Ltd. (4527.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
As of 11:35AM JST. Market open.
| Previous close | 3,280.00 |
| Open | 3,234.00 |
| Bid | 3,236.00 x 0 |
| Ask | 3,237.00 x 0 |
| Day's range | 3,221.00 - 3,269.00 |
| 52-week range | 2,640.50 - 4,117.00 |
| Volume | |
| Avg. volume | 945,249 |
| Market cap | 738.942B |
| Beta (5Y monthly) | -0.14 |
| PE ratio (TTM) | 23.97 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 30.00 (0.91%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
- Reuters SG
Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and founding family members of Eu Yan Sang, according to a separate statement issued by Tower Capital Asia on Thursday.
© 2024 Yahoo. All rights reserved.